Please login to the form below

Not currently logged in
Email:
Password:

Flexus

This page shows the latest Flexus news and features for those working in and with pharma, biotech and healthcare.

BMS boosts immuno-oncology with $2.3bn IFM buy

BMS boosts immuno-oncology with $2.3bn IFM buy

It paid $1.25bn - including $800m upfront - for IDO specialist Flexus in 2015 for example.

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Pharma deals in February 2015 Pharma deals in February 2015

    February saw BMS further signal its intention to lead in this space announcing two simultaneous deals, the acquisition of Flexus Biosciences and a collaboration with Rigel. ... checkpoint inhibition. Upon completion the Flexus team will spin-out the

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Salix Pharmaceuticals/ Valeant Pharmaceuticals. GI products. Corporate acquisition. 14, 500. Flexus Biosciences/ BMS.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics